Building on the observation of elevated CD39 expression in ovarian cancer and the elevated CD39 expression in activated CAR-T cells, we constructed huCD39 mAb secreting MSLN CAR-T cell (Figure 5A and Figure 5D). This evidence concerns the gene ENTPD1 and ovarian carcinoma.